The bioprocess controllers and automation systems market is projected to be grow at an annualized growth rate of 10% by 2030, claims Roots Analysis

Owing to their advanced features and cost saving potential, bioprocess controllers and automation systems have been adopted widely by stakeholders in order to optimize and fasten the manufacturing process of biologics

Roots Analysis has announced the addition of “Bioprocess Controllers and Automation Systems Market, 2021-2030” report to its list of offerings.

The bioprocess controllers and automation systems have turned out to be a process optimization solution for the biopharmaceutical industries, overcoming the inadequacies of the traditional bioreactor systems. Amidst the COVID-19 pandemic, the increasing demand for biologics has led to the surge in the adoption rate of the aforementioned systems. As a result, several bioprocess equipment developers stepped up to offer more controlled and automated systems in order to increase the productivity, shorten production timelines, reduce cost of goods, and increase flexibility of the bioprocess.

To order this 230+ page report, which features 105+ figures and 105+ tables, please visit https://www.rootsanalysis.com/reports/bioprocess-controllers-and-automation-systems-market.html

Key Market Insights

120+ bioprocess controllers and automation systems are being developed by various players in this domain
Over 40% of the bioprocess controllers and automation systems are being offered to optimize the downstream processes, followed by over 30% controllers, which are used to optimize upstream processes.

Over 25 companies claim to provide development services related to bioprocess controllers and automation systems
The domain is featured by the presence of nearly 40% small players; of which, over 30% of players are developing upstream controllers. Further, more than 50% of these players offering bioprocess controllers and automation systems are based in Europe.

More than 3,500 patents have been filed / published related to the bioprocess controllers and automation systems, as of July 2021
Close to 70% of these were patent applications, while the remaining were granted patents. Of the total patent applications, close to 65% were filed in North America, while around 30% patents were filed in Europe.

Europe is anticipated to capture over 42% of the market share by 2030
Bioprocess controllers and automation systems developed for preclinical / clinical scale operations currently capture the highest share (~75%) in the market; this trend is unlikely to change in the foreseen future. Further, upstream / downstream controllers hold the major share (~60%) in bioprocess controllers and automation systems market.

To request a sample copy / brochure of this report, please visit https://www.rootsanalysis.com/reports/bioprocess-controllers-and-automation-systems-market.html

Key Questions Answered

Who are the leading players engaged in the development of bioprocess controller and automation systems?
What are the different application areas where bioprocess controller and automation systems can be used?
What are the key features of bioprocess controller and automation systems?
How has the intellectual property landscape of bioprocess controller and automation, evolved over the time?
What are the key trends within the bioprocess controllers and automation systems market?
How is the current and future opportunity likely to be distributed across key market segments?

By 2030, the financial opportunity within the bioprocess controllers and automation systems market has been analyzed across the following segments:

Type of Controllers
Upstream / Downstream controller systems
Bioprocess control software

Analysis by Scale of Operation
Preclinical / Clinical Operation
Commercial Operation

Analysis by Mode of Operation
Batch / Fed-batch
Perfusion

Analysis by Types of Systems
Single-use systems
Stainless Steel / Other Systems

Analysis by Geographical Regions
North America
Europe
Asia Pacific and Rest of the World

The report also features inputs from eminent industry stakeholders, according to whom, the several bioprocessing companies are likely to adopt bioprocess controllers and automation systems in the foreseen future. The report includes detailed transcripts of discussion held with prominent industry representatives.

The research includes profiles of key players (listed below); each profile features a tabulated overview of company, product portfolio, recent developments, and an informed future outlook.
Applikon Biotechnology
Cytiva
Repligen
Sartorius
Sepragen
Solaris Biotech
Sysbiotech
Thermo Fisher Scientific

For additional details, please visit
https://www.rootsanalysis.com/reports/bioprocess-controllers-and-automation-systems-market.html or email sales@rootsanalysis.com

You may also be interested in the following titles:
1. Continuous Manufacturing Equipment Providers Market: Industry Trends and Global Forecast, 2021-2030
2. Single-Use Bioreactors Market (2nd Edition): Industry Trends and Global Forecast, 2021-2030
3. Telemedicine Tools and Software Providers Market: Industry Trends and Global Forecasts, 2021-2030
4. Cloud-based Solutions for Drug Discovery, Development and Manufacturing Market: Industry Trends and Global Forecast, 2021-2030

Contact:
Ben Johnson
+1 (415) 800 3415
ben.johnson@rootsanalysis.com

Contact:
Gaurav Chaudhary
gaurav.chaudhary@rootsanalysis.com

Roots Analysis
A430, 4th Floor,
Bestech Business Towers, Sector 66, Mohali, India
sales@rootsanalysis.com
+1 (415) 800 3415
+44 (122) 391 1091
Web: https://www.rootsanalysis.com/
LinkedIn: https://in.linkedin.com/company/roots-analysis
Twitter: https://twitter.com/RootsAnalysis.com

We specialise in analysing areas which have lacked quality research so far or require more focussed understanding within the broader industry. All our reports are structured in a way to enable the reader develop a thorough perspective on the given subject. Apart from writing reports on identified areas, we also provide bespoke research / consulting services dedicated to serve our clients in the best possible way.

This release was published on openPR.